Contraindications to magnetic resonance imaging

Heart

Volumn 94, Issue 7, 2008, Pages 943-948

  Dill, Thorsten ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; COSMETIC; METAL;

ANNULOPLASTY; ARTIFICIAL HEART PACEMAKER; BREAST FEEDING; CLAUSTROPHOBIA; COCHLEA PROSTHESIS; CONTRACEPTIVE DEVICE; CORONARY STENT; DEFIBRILLATOR; DEVICE; FOREIGN BODY; HEART VALVE PROSTHESIS; HEMODYNAMICS; IMPLANT; KIDNEY FAILURE; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RADIOFREQUENCY; REVIEW; TATTOO;

CARDIOVASCULAR DISEASES; CONTRAST MEDIA; DEFIBRILLATORS, IMPLANTABLE; FOREIGN BODIES; HUMANS; MAGNETIC RESONANCE IMAGING; METALS; PACEMAKER, ARTIFICIAL; PROSTHESES AND IMPLANTS; STENTS;

EID: 46249100475     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.125039     Document Type: Review

References (25)

1. Shellock FG. Reference manual for magnetic resonance safety, implants, and devices, 2006 ed. Los Angeles: Biomedical Research Publishing, 2006. ▶ Extensive overview of MRI compatibility of implants and devices.
2. Shellock FG. Pocket guide to MR procedures and metallic objects: update 2001. Philadelphia: Lippincott Williams & Wilkins, 2001.
3. Prasad SK, Pennell DJ. Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices. Heart 2004;90:1241-4.
4. Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention. Endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Cardiology Magnetic Resonance. Circulation 2007;116:2878-91. ▶ Recently published comprehensive scientific statement summarising safety issues for MRI in patients with cardiovascular devices.
5. Cowper SE. Nephrogenic systemic fibrosis: an overview. J Am Coll Radiol 2008;5:23-8. ▶ Excellent summary of the current knowledge on nephrogenic systemic fibrosis.
6. Kanal E, Barkovich AJ, Bell C, et al. ACR Blue Ribbon Panel on MR Safety. ACR guidance document for safe MR practices: 2007. Am J Roentgenol 2007;188:1447-74. ▶ Excellent article summarising all information required on MR safety.
7. Shellock FG, Kanal E. Aneurysm clips: effects of long-term and multiple exposures to a 1.5-T MR system. Radiology 1999;210:563-5.
8. Shellock FG. Biomedical implants and devices: assessment of magnetic field interactions with a 3.0-Tesla MR system. J Magn Reson Imaging 2002;16:721-32.
9. Porto I, Selvanayagam J, Ashar V, et al. Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation. Am J Cardiol 2005;96:366-8.
10. Edwards MB, Taylor KM, Shellock FG. Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1.5 T. J Magn Reson Imaging 2000;12:363-9.
11. Shellock FG, Valencerina S. Septal repair implants: evaluation of magnetic resonance imaging safety at 3 T. Magn Reson Imaging 2005;23:1021-5.
12. Dempsey MF, Condon B. Thermal injuries associated with MRI. Clin Radiol 2001;56:457-65.
13. Fisher JD. MRI: safety in patients with pacemakers or defibrillators: is it prime time yet? Pacing Clin Electrophysiol 2005;28:263.
14. Martin ET. Can cardiac pacemakers and magnetic resonance imaging systems co-exist? Eur Heart J 2005;26:325-7.
15. Faris OP, Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter- defibrillator patients. Circulation 2006;114:1232-3.
16. Shinbane JS, Coletti PM, Shellock FG. MR in patients with pacemakers and ICDs: defining the issue. J Cardiovasc Magnetic Resonance 2007;9:5-13. ▶ Very good overview summarising the current controversy on MRI in patients with pacemakers and ICDs.
17. Shellock FG. New metallic implant used for permanent contraception in women: evaluation of MR safety. Am J Radiol 2001;178:1513-16.
18. Whitney D, Shellock FG. Magnetic resonance imaging and permanent cosmetics (tattoos): survey of complications and adverse events. J Magn Reson Imaging 2002;15:180-4.
19. Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004;232:635-52. ▶ Extensive review providing an overview on MR biologic effects, safety issues, and current guideline recommendations.
20. Dewey M, Schink T, Dewey CF. Claustrophobia during magnetic resonance imaging: cohort study in over 55.000 patients. J Magn Reson Imaging 2007;26:1322-7.
21. Stecco A, Saponaro A, Carriero A. Patient safety issues in magnetic resonance imaging: state of the art. Radiol Med 2007;112:491-508. ▶ Review summarising current safety issues and contraindications to MRI.
22. Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999;10:477-84.
23. Hylton M. Suspension of breastfeeding following gadopentetate dimeglumine administration. Radiology 2000;216:325-6.
24. Bongartz G. Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? MAGMA 2007;2:57-62.
25. Wiginton CD, Kelly B, Oto A, et al. Gadolinium based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol 2008;190:1-9.